MPS II – The Genetic Marker Potential

MPS II – The Genetic Marker Potential

← Back to Series 

Massively parallel sequencing (MPS) is an exciting technology that holds promise for enhancing the capabilities of the forensic DNA analyst. However, there are several challenges that confront implementation of an MPS system into the crime laboratory, which include: training and education on fundamentals of the chemistry, functionality and genetic marker systems, validation criteria and study design, policy and data procedure developments related to CODIS operations, and perceived admissibility and privacy issues. This four-part webinar series will address these and other areas of interest, providing foundational information on the two available MPS systems, covering platforms and chemistries, throughput, genetic markers, bioinformatics, validation requirements, applications, and potential admissibility issues.

In this second webinar, “The Genetic Marker Potential,” the panelists discuss the different genetic markers which can be typed, including the future roles and benefits of these markers, as well as considerations for CODIS compatibility and expansion. In addition, the discussions cover the pros and cons of the different sized multiplexes, thereby identifying the potential benefits this promising technology can bring to forensic science.

Funding for this Forensic Technology Center of Excellence event has been provided by the National Institute of Justice.

A certificate of completion is available for all who register and attend this webinar.

Bruce Budowle
Lilliana Moreno
Niels Morling
Tim McMahon
Dieter Deforce
Doug Storts
Peter de Knijff
Manfred Kayser
Patricia Melton

Register Here

Please contact us at for any questions.

Each of our webinars is archived within about two weeks of the live date and will be posted on our website. Please subscribe to our newsletter for notifications.